These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Study of the process of promutagen biotransformation by the Ames test. I. The role of conjugation with glutathione in the modification of the mutagenic activity of nitrosomorpholine, diethylnitrosamine and cyclophosphamide]. Fonshteĭn LM, Loknitskaia NN, Rotenberg IuS. Genetika; 1985 Nov; 21(11):1821-7. PubMed ID: 3908219 [Abstract] [Full Text] [Related]
23. Metabolism and binding of cyclophosphamide and its metabolite acrolein to rat hepatic microsomal cytochrome P-450. Marinello AJ, Bansal SK, Paul B, Koser PL, Love J, Struck RF, Gurtoo HL. Cancer Res; 1984 Oct; 44(10):4615-21. PubMed ID: 6380709 [Abstract] [Full Text] [Related]
24. Mutagenicity of urine from rats and mice treated with acrylonitrile. Lambotte-Vandepaer M, Duverger-van Bogaert M, de Meester C, Poncelet F, Mercier M. Toxicology; 1980 Oct; 16(1):67-71. PubMed ID: 6996219 [Abstract] [Full Text] [Related]
25. The spectrum of enzymes involved in activation of 2-aminoanthracene varies with the metabolic system applied. Veres Z, Török G, Tóth E, Vereczkey L, Jemnitz K. Mutat Res; 2005 Sep 05; 586(1):18-27. PubMed ID: 16006184 [Abstract] [Full Text] [Related]
26. Mutagenicity studies in Salmonella typhimurium on some carcinogenic N-nitramines in vitro and in the host-mediated assay in rats. Khudoley V, Malaveille C, Bartsch H. Cancer Res; 1981 Aug 05; 41(8):3205-10. PubMed ID: 7018677 [Abstract] [Full Text] [Related]
32. [Effect of metabolic changes in the liver on the cytotoxic activity of cyclophosphamide in the incisor of rats]. Rosenfeld E, Ponsold W, Hoffmann P. Biomed Biochim Acta; 1988 Aug 05; 47(8):761-6. PubMed ID: 3240306 [Abstract] [Full Text] [Related]
34. Mutagenesis assays on urines produced by patients administered adriamycin and cyclophosphamide. Newman MA, Hee SS, Schoeny RS. Environ Mol Mutagen; 1990 Aug 05; 16(3):189-203. PubMed ID: 2209575 [Abstract] [Full Text] [Related]
35. Antimutagenesis of beta-carotene to mutations induced by quinolone on Salmonella typhimurium. Arriaga-Alba M, Rivera-Sánchez R, Parra-Cervantes G, Barro-Moreno F, Flores-Paz R, García-Jiménez E. Arch Med Res; 2000 Aug 05; 31(2):156-61. PubMed ID: 10880720 [Abstract] [Full Text] [Related]
36. Importance of pharmacokinetic studies on cyclophosphamide (NSC-26271) in understanding its cytotoxic effect. Donelli MG, Bartosek I, Guaitani A, Martini A, Colombo T, Pacciarini MA, Modica R. Cancer Treat Rep; 1976 Apr 05; 60(4):395-401. PubMed ID: 1277213 [Abstract] [Full Text] [Related]
37. Mutagenic activity of cyclophosphamide, ifosfamide, and trofosfamide in different genes of escherichia coli and salmonella typhimurium after biotransformation through extracts of rodent liver. Ellenberger J, Mohn G. Arch Toxicol; 1975 Apr 05; 33(3):225-40. PubMed ID: 1096853 [Abstract] [Full Text] [Related]
40. Quantitative correlation between the metabolism and the mutagenic activity of N-nitrosopyrrolidine. Gilbert PJ, Rollmann B, de Valkeneer FD, Rondelet J, Mercier M, Poncelet F. Toxicology; 1984 Jan 05; 29(3):261-70. PubMed ID: 6364456 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]